[1]
M. Satyagraha, G. Sheridan, V. Laryan, and G. Hidayatullah, “TOCILIZUMAB AS MONOCLONAL ANTIBODY THERAPY IN OVERCOMING ACUTE RESPIRATORY DISTRESS SYNDROME IN COVID-19 PATIENTS”, JIMKI, vol. 9, no. 3, pp. 92-101, Apr. 2022.